|
Volumn 3, Issue 1, 2002, Pages 43-54
|
Chronic tendon pain: No signs of chemical inflammation but high concentrations of the neurotransmitter glutamate. Implications for treatment?
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANALGESIC AGENT;
CORTICOSTEROID;
GLUTAMIC ACID;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NEUROTRANSMITTER;
NONSTEROID ANTIINFLAMMATORY AGENT;
PIROXICAM;
PLACEBO;
PROSTAGLANDIN E2;
STEROID;
ACHILLES TENDON;
ARTICLE;
CHRONIC PAIN;
CLINICAL TRIAL;
CONCENTRATION RESPONSE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG TARGETING;
ENZYME HISTOCHEMISTRY;
FEMALE;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
IMMUNOREACTIVITY;
IN VIVO STUDY;
INFLAMMATION;
MAJOR CLINICAL STUDY;
MALE;
MICRODIALYSIS;
MUSCLE BIOPSY;
PATELLA TENDON;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
TENDON DISEASE;
ANIMALS;
CHRONIC DISEASE;
GLUTAMIC ACID;
HUMANS;
MICRODIALYSIS;
PAIN;
RECEPTORS, N-METHYL-D-ASPARTATE;
TENDINOPATHY;
|
EID: 0036215207
PISSN: 13894501
EISSN: None
Source Type: Journal
DOI: 10.2174/1389450023348028 Document Type: Article |
Times cited : (130)
|
References (97)
|